Researchers say if their results are confirmed through further study they are optimistic the approach could be used to treat chronic infections for the first time.
In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, researchers have identified a vulnerability that opens ...
In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center ...
Broad-Spectrum Antiviral NV-387 Phase II Clinical Trial Responding to MPox Pandemic in Africa, Readying to Tackle Bird Flu ...
On Hacking Humans, Dave Bittner, Joe Carrigan, and Maria Varmazis (also host of N2K's daily space podcast, T-Minus), are once again sharing the latest in social engineering scams, phishing schemes, ...
A novel approach developed by a UB physician-scientist and colleagues to cure hepatitis C virus in people with opioid use ...
Some people may remain ill after COVID infection because the virus still lurks in their bodies. The looming question now is: ...
The NHS will automatically test patients for HIV, Hepatitis B and Hepatitis C unless they opt out at 90 hospitals.
WASHINGTON In a speech on the Senate floor, U.S. Senate Democratic Whip Dick Durbin (D-IL) outlined his serious concerns with Robert F. Kenney, Jr., President ...
Researchers at Oregon Health & Science University have developed the first transgenic nonhuman primate model—genetically ...
9d
Zacks.com on MSNGILD Stock Up on Q4 Earnings and Sales Beat & Upbeat '25 GuidanceGilead Sciences, Inc. GILD reported better-than-expected fourth-quarter results and provided an upbeat guidance for 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results